Can-Fite Biopharma Ltd. current report, Q4 FY2016

Business Context and Reporting Period

This Form 6-K filing by Can-Fite Biopharma Ltd. is dated November 21, 2016, covering the month of November 2016. The filing serves to announce the Company's Annual General Meeting of Shareholders scheduled for December 26, 2016, at its offices in Petach Tikva, Israel.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.

Material Changes

No material financial changes versus a prior comparable period are reported in this filing. The document focuses solely on the logistics and voting procedures for the upcoming Annual General Meeting.

Guidance, Outlook, and Management Commentary

The filing includes no management commentary on business outlook, risks, contingencies, or unusual items. It strictly details the submission of the Notice and Proxy Statement, a Proxy Card for ordinary share holders, and a Voting Instruction Card for American Depositary Share holders.

Key Facts for Investor Verification

  • Annual General Meeting Date: December 26, 2016.
  • Meeting Time: 10:00 a.m. (Israel time).
  • Meeting Location: Company offices in Petach Tikva, Israel.
  • Voting Materials: Proxy cards and voting instruction cards are attached as Exhibits 99.2 and 99.3.
  • Financial Data: None included in this specific filing.